Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study | AVESİS

Istanbul University Research Information System

Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study

Basaran G. A. , Guney N. , Saip P., Iyikesici S., Kaya H., Yazici H. , ...More

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.90-91

Publication Type: Conference Paper / Summary Text
Volume: 17
City: İstanbul
Country: Turkey
Page Numbers: pp.90-91